Today in Oncology
Phase III Trial Shows No Survival Benefit for Eribulin vs Capecitabine in ...1/30/2015 3:39:44 PM - Matthew Stenger
High-Risk Prostate Cancer Detection More Likely With Targeted MRI/Ultrasou...1/30/2015 2:42:35 PM - The ASCO Post
Intraperitoneal Oxidative Stress Induces Tumoricidal Immune Response in Pa...December 15, 2014, Volume 5, Issue 20 - Matthew Stenger
Prospective Cohort Study Indicates No Association Between Migraine and Bre...1/30/2015 2:13:10 PM - Matthew Stenger
Researchers Pinpoint Two Genes That Trigger Most Severe Form of Ovarian Ca...1/30/2015 1:16:59 PM - The ASCO Post
NIH Awards Two New Grants to Explore the Understanding of Genomics Researc...September 1, 2014, Volume 5, Issue 14 - The ASCO Post
Ibrutinib Active in Previously Untreated and Relapsed/Refractory CLL With ...1/30/2015 11:11:10 AM - Matthew Stenger
Study Finds Fear of Cancer Can Be Either a Facilitator or Deterrent to Get...1/29/2015 2:49:51 PM - Jo Cavallo
Breaking the Silence About Breast Cancer in the Arab WorldOctober 15, 2014, Volume 5, Issue 16 - Ronald Piana
Inherited Gene Variation Helps Explain Drug Toxicity in ALL Patients of Ea...1/29/2015 2:26:12 PM - The ASCO Post
Protein-Based Therapy Shows Promise Against Resistant ALL in Preclinical S...1/29/2015 2:21:14 PM - The ASCO Post
FDA Approves New Indication for Ibrutinib in Waldenström's Macroglobulinem...1/29/2015 4:06:19 PM - The ASCO Post
Top 5 Breakthroughs in the Treatment of Advanced Lung CancerDecember 1, 2014, Volume 5, Issue 19 - Charlotte Bath
Retrospective Study Indicates Improved Disease-Free Survival for Complete ...1/29/2015 12:25:57 PM - Matthew Stenger
No Benefit of High- vs Standard-Dose Radiotherapy or for Addition of Cetux...1/29/2015 11:52:46 AM - Matthew Stenger
Young Adults With Cancer: Unique Issues Highlight Importance of Patient-Ce...November 15, 2014, Volume 5, Issue 18 - Caroline McNeil
Study Uncovers Range of Molecular Alterations in Head and Neck Squamous Ce...1/28/2015 3:46:08 PM - The ASCO Post
Final Survival Analysis in COU-AA-302 Shows Benefit of Adding Abiraterone ...1/28/2015 2:10:26 PM - Matthew Stenger
LCS6 Genotype Not Associated With KRAS Mutation Status or Outcome in Stage...September 15, 2014, Volume 5, Issue 15 - Matthew Stenger
Testosterone Therapy May Help Some Men With Castration-Resistant Prostate ...1/28/2015 1:35:48 PM - The ASCO Post
Pre- and Postdiagnosis Physical Activity and TV Viewing Affect Overall Sur...1/28/2015 12:39:31 PM - Matthew Stenger
Supplemental New Drug Application Submitted for Carfilzomib for Relapsed M...1/28/2015 12:36:43 PM - The ASCO Post
Crizotinib in ROS1-Positive NSCLC: A Next Step ForwardJanuary 25, 2015, Volume 6, Issue 1 - Jacek Jassem, MD, PhD, and Rafał Dziadziuszko, MD, PhD
Age-Related Clonal Hematopoiesis Associated With Increased Risk of All-Cau...1/27/2015 3:19:48 PM - Matthew Stenger
RTOG 9804 Trial Shows Reduced Local Failure With Radiotherapy After Breast...1/27/2015 2:20:36 PM - Matthew Stenger
Gardasil 9 Adds Protection Against Cancer Caused by Additional Human Papil...January 25, 2015, Volume 6, Issue 1 - Matthew Stenger
Study Finds Many Women Lack Understanding of Their Breast Cancer, Especial...1/27/2015 12:10:22 PM - Jo Cavallo
Clonal Hematopoiesis With Somatic Mutations Increases With Age and Increas...1/26/2015 12:58:24 PM - Matthew Stenger
Preoperative Rodent Cancer: Patient of Charles Moore, MD, Albumen Print, L...December 1, 2014, Volume 5, Issue 19 - The ASCO Post
Analysis of Unexplored Part of Human Genome May Lead to Cancer Biomarker D...1/26/2015 12:55:16 PM - The ASCO Post
New Breast Exam Nearly Quadruples Detection of Invasive Breast Cancers Whe...1/27/2015 4:38:00 PM - The ASCO Post
Sorafenib Plus Everolimus Shows Some Activity in Progressive Unresectable ...1/26/2015 11:40:37 AM - Matthew Stenger
Jesse L. Steinfeld, MD, Past Surgeon General, ASCO President, Dies at 87September 1, 2014, Volume 5, Issue 14 - Ronald Piana
Genetic Diagnosis by Exome Sequencing Feasible for Familial Colorectal Can...1/23/2015 3:43:29 PM - Matthew Stenger
No Utility of AJCC Stage IA vs Stage IB Designation in Breast Cancer1/23/2015 3:38:31 PM - Matthew Stenger
Radiation Oncologist Stephen Hahn, MD, to Join MD AndersonOctober 15, 2014, Volume 5, Issue 16 - The ASCO Post
RTOG 9910 Trial Shows No Benefit of Longer Androgen Suppression Before Rad...1/23/2015 3:34:34 PM - Matthew Stenger
Head and Neck Cancers in Young Adults More Likely to Be a Result of Inheri...1/23/2015 3:32:12 PM - The ASCO Post
Metastatic Breast Cancer Alliance Report Finds Research for the Disease Is...November 15, 2014, Volume 5, Issue 18 - Jo Cavallo
Researchers Identify Potential Treatment Targeting Proliferation Pathway i...1/23/2015 3:05:15 PM - The ASCO Post
Featured Columnists
What Is a Physician? Call a Spade a Spade
Chandrakanth Are, MBBS, FRCS, FACS
Transplants for AML in First Remission: A Great Leap Forward, Sideways, or Backward?
Robert Peter Gale, MD, PhD, DSc(hc), FACP, Hillard M. Lazarus, MD, FACP, and Peter H. Wiernik, MD, FACP, FASCO
When Should We Stop Prescribing?
John F. Smyth, MD
Expert Opinions
Breast Health Global Initiative Tackles Third-World Health Care
Incorporating Physical Medicine and Rehabilitation Into Palliative Care
Meeting News
Carfilzomib-Based Triplet Yields ‘Unprecedented’ Duration of Remission in ... Ovarian Suppression Plus Hormonal Therapy May Be Practice-Changing in Prem... Brentuximab Vedotin Added to Standard Therapy for Advanced-Stage Hodgkin ... Post-Transplant Brentuximab Vedotin Improved Progression-Free Survival in... More Meeting NewsJournal Spotlight
Vitamin D Protects Against Colorectal Cancer by Boosting the Immune System Nivolumab Improves Outcomes vs Dacarbazine in Previously Untreated Advance... Coupling Head and Neck Cancer Screening and Lung Cancer Scans Could Improv... No Benefit of Adding Lapatinib to Fulvestrant in Hormone Receptor–Positive... More Journal SpotlightsHealth-Care Policy
Molecular Pathologists vs the FDA: Proposed Regulation of Laboratory-Developed Tests Sparks Debate ASCO and AACR Call for Regulation of E-Cigarettes and Other Electronic Nicotine Delivery Systems CMS Issues Preliminary Decision to Cover Annual Lung Cancer Screening Policy Issues in Molecularly Targeted Therapy: The Science, the Money, the Applications More Health-care PolicyDrugs & Regimens
Nilotinib With Low-Intensity Chemotherapy Useful in Elderly Patients With Philadelphia Chromosome–Positive ALL Neoadjuvant Therapy in Triple-Negative Breast Cancer: Impact of Subtype Pembrolizumab Holds Promise in Breast Cancer, Early Studies Suggest BOLERO-1: Everolimus Plus Trastuzumab/Paclitaxel Misses the Mark in First‑Line HER2-Positive Advanced Breast Cancer More Drugs & RegimensOncology Worldwide
Breast Health Global Initiative Tackles Third-World Health Care Breaking the Silence About Breast Cancer in the Arab World Despite Growing Awareness, the Global Crisis of Untreated Cancer Pain Persists Effective Prevention Measures Urgently Needed to Prevent Global Cancer Crisis More Oncology Worldwide
Current Issue
January 25, 2015
Volume 6, Issue 1
View the
digital edition of
The ASCO Post
Supplement
Narratives in Oncology
/
advertisement
CATEGORIES
Breast cancerProstate cancerAppointmentsLeukemiaLung cancerDirect from ASCOColorectal cancerLymphomaAwardsIntegrative careMultiple myelomaGastrointestinal cancerOtherMelanomaMolecular researchHead and Neck cancerTechnologyRenal cell cancerDrug safetyHealth-care policyPerspective More Categories
advertisement
advertisement